In vitro ability of Staphylococcus aureus isolates from bacteraemic patients with and without metastatic complications to invade vascular endothelial cells
Open Access
- 1 October 2007
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 56 (10) , 1290-1295
Abstract
Invasion of vascular endothelial cells is thought to be a critical step in the development of metastatic infections in patients with Staphylococcus aureus bacteraemia. This study was designed to evaluate the association between the ability to invade endothelial cells and metastatic infection by S. aureus. Patients with metastatic infection were identified among those with community-acquired S. aureus bacteraemia in a tertiary referral hospital. Patients with simple bacteraemia caused by S. aureus over the same period served as the control group. The ability of each clinical isolate to invade endothelial cells was evaluated by counting the number of intracellular organisms 1 h after inoculation onto human umbilical vein endothelial cells in vitro. The cytotoxic activity of intracellular S. aureus was determined 24 h after internalization, and expressed as the percentage of cells killed. The clinical isolates varied in invasiveness and cytotoxicity. The median invasiveness, relative to S. aureus reference strain ATCC 29213, was 145 % in the cases (n=10) [interquartile range (IQR) 103–160] and 153 % (IQR 111–173) in the controls (n=11; P=0.44). The median cytotoxicity was 59.4 % (IQR 47–68) in the cases and 65.2 % (IQR 50–74) in the controls (P=0.44). Differences in the ability of S. aureus to invade and destroy vascular endothelial cells in vitro were not associated with the development of metastatic complications in patients with S. aureus bacteraemia. This implies that the invasiveness and toxicity of S. aureus for endothelial cells may not be major determinants of metastatic infection.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence and Clinical Implications of Staphylococcus aureus with a Vancomycin MIC of 4 µ g/ml in KoreaMicrobial Drug Resistance, 2006
- Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissueBone, 2005
- Risk Factors For Hematogenous Complications of Intravascular Catheter--Associated Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2005
- The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infectionsCurrent Opinion in Infectious Diseases, 2003
- Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugsQJM: An International Journal of Medicine, 1998
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- Community and hospital acquired Staphylococcus aureus septicaemia: 115 cases from a Dublin teaching hospitalJournal of Infection, 1996
- The Current Spectrum of Staphylococcus aureus Infection in a Tertiary Care HospitalMedicine, 1994
- Course and Outcome of Bacteremia Due to Staphylococcus aureus: Evaluation of Different Clinical Case DefinitionsClinical Infectious Diseases, 1993
- Prospective Study of 114 Consecutive Episodes of Staphylococcus aureus BacteremiaClinical Infectious Diseases, 1987